Services
FibroLux™ Laser Therapy
Break Free from Fibromyalgia Pain with FibroLux™ Laser Therapy
Drug-Free Relief for Pain Associated with Fibromyalgia
Did you know that prescription medications only work for 10% of those suffering with Fibromyalgia?
If you're one of the many suffering from Fibromyalgia pain, we know that it can be frustrating. We're excited to offer
a new innovative therapy that is helping reduce pain for those suffering from this debilitating condition-FibroLux laser therapy.
Meet FibroLux laser therapy
This gentle, soothing treatment can be safely combined with your current treatments to temporarily relieve pain associated with Fibromyalgia.
Laser therapy, or photobiomodulation (PBM), utilizes light to inhibit the stimulation of pain sensors, and transmission of pain signals along
the nerve fibers resulting in effective pain relief. Additionally, PBM can stimulate the release of the body's natural pain-fighting chemicals.
First FDA-cleared therapy laser for the temporary relief pain associated with fibromyalgia
Reduces tender point count
Decreases mean pain ratings
Improves Fibromyalgia Impact Questionnaire (FIQ) scores
Fast treatment times
PBM reduces overall pain associated with FMS by up to 60%.
1 Additionally, PBM reduces the number of tender points by 37%-57%.
2 PBM has also
reduced the impact of fibromyalgia syndrome on a person's life. This was measured using the Fibromyalgia Impact Questionnaire.
3 These outcomes
(reduction in tender points and pain and increase in function) are magnified when PBM treatment is followed by exercise.
4
About Fibromyalgia
Fibromyalgia syndrome (FMS) is defined by the American College of Rheumatology (ACR) as a chronic widespread pain and tenderness in specific tender
points characterized by muscular tenderness, pain, fatigue, and cognitive difficulties.5 It is not an inflammatory condition, nor does it lead to
joint impairment or deformities.
FMS is common worldwide; it affects approximately 2-8% of the general population. Females are diagnosed three times higher than males.6 Overall economic
impact of FMS is $12-$14 billion on indirect and direct costs plus $31 billion in lost productivity. The average out of pocket expense for an FMS
patient with insurance was $5,310 annually.7
The first line of treatment for pain is medication. The FDA has approved three drugs to treat fibromyalgia: antidepressants duloxetine (Cymbalta) and
milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). These medications effectively reduce FMS pain by half in approximately 10% of
the FMS patients who use them.8
Contact us today to see if FibroLux laser therapy is an option for you.
The FibroLux Laser is FDA-cleared under NHN 510(k) Number K212189 and is indicated for adjunctive use in providing temporary relief of pain associated with fibromyalgia.
Sources
1 Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33: 160-72.
2 Häuser W, Ablin J, Fitzcharles M, Littlejohn G, Luciano J, Usui C, et al. Fibromyalgia. Nat Rev Dis Primers. 2015; 13(1): 15022.
3 Weidebach WF. Fibromyalgia: evidence of a neurophysiologic substrate. Rev Assoc Med Bras. 2002, 48: 291-292.
4 Sanada K, Diez MA, Valero MS, et al. Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: A systematic review. Arthritis Res Ther 2015; 17:272.
5 Marcus DA. Fibromyalgia: Diagnosis and treatment options. Gend Med. 2009 6:139-151.
6 Medication for the treatment of fibromyalgia. NCBI, 2018.
7 Yeh S, Hong C ,Shih M, et al. Low level laser therapy for fibromyalgia: a systematic review and meta-analysis. Pain Phys, 2019 22:241-254.
8 InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Medication for the treatment of fibromyalgia. 2018 Mar 8. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK492992/
© 2023 Multi Radiance Medical. All rights reserved. U.S. and international patents pending
